Insider Transactions by Liu David Y

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PTGXProtagonist Therapeutics, IncLiu David YChief R&D Strategy OfficerNov 16, 2022Option Exercise$2.31100,479231,802167,590Nov 17, 2022, 06:24 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerFeb 28, 2022Option Exercise$24.282,11951,44966,538Mar 02, 2022, 08:38 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerAug 17, 2021Option Exercise$28.7224,779711,58973,033Aug 19, 2021, 05:49 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerAug 06, 2019Sale$8.853,39530,04449,802Aug 08, 2019, 06:17 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerMar 01, 2019Sale$8.038106,50451,197Mar 04, 2019, 06:35 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerFeb 06, 2019Sale$7.743,82129,56237,007Feb 08, 2019, 05:30 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerMar 12, 2018Sale$12.757,00089,23518,528Mar 13, 2018, 04:48 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerMar 02, 2018Sale$10.941,75019,15414,197Mar 02, 2018, 07:17 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerJan 16, 2018Sale$10.941,75019,1544,697Jan 17, 2018, 04:34 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerDec 18, 2017Sale$10.941,75019,1544,697Dec 20, 2017, 09:13 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerNov 30, 2017Sale$10.941,75019,1544,697Dec 01, 2017, 06:56 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerNov 13, 2017Option Exercise$10.0114,000140,1117,322Nov 15, 2017, 07:14 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerAug 28, 2017Option Exercise$9.617,00067,2355,500Aug 29, 2017, 07:48 PM
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerJul 10, 2017Option Exercise$7.297,00050,9955,500Jul 12, 2017, 05:55 PM